Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 322
Filter
1.
Nat Commun ; 13(1): 5208, 2022 09 05.
Article in English | MEDLINE | ID: mdl-36064857

ABSTRACT

Adipose tissue macrophage (ATM) inflammation is involved with meta-inflammation and pathology of metabolic complications. Here we report that in adipocytes, elevated lactate production, previously regarded as the waste product of glycolysis, serves as a danger signal to promote ATM polarization to an inflammatory state in the context of obesity. Adipocyte-selective deletion of lactate dehydrogenase A (Ldha), the enzyme converting pyruvate to lactate, protects mice from obesity-associated glucose intolerance and insulin resistance, accompanied by a lower percentage of inflammatory ATM and reduced production of pro-inflammatory cytokines such as interleukin 1ß (IL-1ß). Mechanistically, lactate, at its physiological concentration, fosters the activation of inflammatory macrophages by directly binding to the catalytic domain of prolyl hydroxylase domain-containing 2 (PHD2) in a competitive manner with α-ketoglutarate and stabilizes hypoxia inducible factor (HIF-1α). Lactate-induced IL-1ß was abolished in PHD2-deficient macrophages. Human adipose lactate level is positively linked with local inflammatory features and insulin resistance index independent of the body mass index (BMI). Our study shows a critical function of adipocyte-derived lactate in promoting the pro-inflammatory microenvironment in adipose and identifies PHD2 as a direct sensor of lactate, which functions to connect chronic inflammation and energy metabolism.


Subject(s)
Adipocytes , Hypoxia-Inducible Factor-Proline Dioxygenases , Inflammation , Lactate Dehydrogenase 5 , Lactic Acid , Macrophages , Adipocytes/immunology , Adipose Tissue/immunology , Animals , Humans , Hypoxia-Inducible Factor-Proline Dioxygenases/genetics , Hypoxia-Inducible Factor-Proline Dioxygenases/immunology , Inflammation/genetics , Inflammation/immunology , Inflammation/pathology , Insulin Resistance/genetics , Insulin Resistance/immunology , Insulin Resistance/physiology , L-Lactate Dehydrogenase/genetics , L-Lactate Dehydrogenase/immunology , Lactate Dehydrogenase 5/genetics , Lactate Dehydrogenase 5/immunology , Lactic Acid/immunology , Macrophages/immunology , Mice , Obesity/genetics , Obesity/immunology , Obesity/pathology , Procollagen-Proline Dioxygenase/genetics , Procollagen-Proline Dioxygenase/immunology , Prolyl Hydroxylases
2.
ACS Appl Mater Interfaces ; 14(5): 6417-6427, 2022 Feb 09.
Article in English | MEDLINE | ID: mdl-35089707

ABSTRACT

A novel double-resonant plasmonic substrate for fluorescence amplification in a chip-based apta-immunoassay is herein reported. The amplification mechanism relies on plasmon-enhanced fluorescence (PEF) effect. The substrate consists of an assembly of plasmon-coupled and plasmon-uncoupled gold nanoparticles (AuNPs) immobilized onto a glass slide. Plasmon-coupled AuNPs are hexagonally arranged along branch patterns whose resonance lies in the red band (∼675 nm). Plasmon-uncoupled AuNPs are sprinkled onto the substrate, and they exhibit a narrow resonance at 524 nm. Numerical simulations of the plasmonic response of the substrate through the finite-difference time-domain (FDTD) method reveal the presence of electromagnetic hot spots mainly confined in the interparticle junctions. In order to realize a PEF-based device for potential multiplexing applications, the plasmon resonances are coupled with the emission peak of 5-carboxyfluorescein (5-FAM) fluorophore and with the excitation/emission peaks of cyanine 5 (Cy5). The substrate is implemented in a malaria apta-immunoassay to detect Plasmodium falciparum lactate dehydrogenase (PfLDH) in human whole blood. Antibodies against Plasmodium biomarkers constitute the capture layer, whereas fluorescently labeled aptamers recognizing PfLDH are adopted as the top layer. The fluorescence emitted by 5-FAM and Cy5 fluorophores are linearly correlated (logarithm scale) to the PfLDH concentration over five decades. The limits of detection are 50 pM (1.6 ng/mL) with the 5-FAM probe and 260 fM (8.6 pg./mL) with the Cy5 probe. No sample preconcentration and complex pretreatments are required. Average fluorescence amplifications of 160 and 4500 are measured in the 5-FAM and Cy5 channel, respectively. These results are reasonably consistent with those worked out by FDTD simulations. The implementation of the proposed approach in multiwell-plate-based bioassays would lead to either signal redundancy (two dyes for a single analyte) or to a simultaneous detection of two analytes by different dyes, the latter being a key step toward high-throughput analysis.


Subject(s)
Gold/chemistry , Metal Nanoparticles/chemistry , Antibodies, Immobilized/chemistry , Antibodies, Immobilized/immunology , Aptamers, Nucleotide/chemistry , Aptamers, Nucleotide/metabolism , Carbocyanines/chemistry , Fluoresceins/chemistry , Glass/chemistry , Humans , Immunoassay/methods , L-Lactate Dehydrogenase/blood , L-Lactate Dehydrogenase/immunology , Limit of Detection , Plasmodium falciparum/enzymology , Protozoan Proteins/blood , Protozoan Proteins/immunology , Surface Properties
4.
Front Immunol ; 12: 749074, 2021.
Article in English | MEDLINE | ID: mdl-34867977

ABSTRACT

In this study, the human immune response mechanisms against Sporothrix brasiliensis and Sporothrix schenckii, two causative agents of human and animal sporotrichosis, were investigated. The interaction of S. brasiliensis and S. schenckii with human monocyte-derived macrophages (hMDMs) was shown to be dependent on the thermolabile serum complement protein C3, which facilitated the phagocytosis of Sporothrix yeast cells through opsonization. The peptidorhamnomannan (PRM) component of the cell walls of these two Sporothrix yeasts was found to be one of their surfaces exposed pathogen-associated molecular pattern (PAMP), leading to activation of the complement system and deposition of C3b on the Sporothrix yeast surfaces. PRM also showed direct interaction with CD11b, the specific component of the complement receptor-3 (CR3). Furthermore, the blockade of CR3 specifically impacted the interleukin (IL)-1ß secretion by hMDM in response to both S. brasiliensis and S. schenckii, suggesting that the host complement system plays an essential role in the inflammatory immune response against these Sporothrix species. Nevertheless, the structural differences in the PRMs of the two Sporothrix species, as revealed by NMR, were related to the differences observed in the host complement activation pathways. Together, this work reports a new PAMP of the cell surface of pathogenic fungi playing a role through the activation of complement system and via CR3 receptor mediating an inflammatory response to Sporothrix species.


Subject(s)
Antigens, Fungal/immunology , Complement System Proteins/immunology , Glycoproteins/immunology , Macrophages/immunology , Sporothrix , Cell Wall/immunology , Complement Activation , Cytokines/immunology , Humans , L-Lactate Dehydrogenase/immunology , Macrophage-1 Antigen/immunology , Macrophages/microbiology , Pathogen-Associated Molecular Pattern Molecules/immunology , Phagocytosis
5.
Sci Rep ; 11(1): 13248, 2021 06 24.
Article in English | MEDLINE | ID: mdl-34168264

ABSTRACT

Multiplex assays for malaria antigen detection can gather data from large sample sets, but considerations for the consistency and quality assurance (QA) of mass testing lack evaluation. We present a QA framework for a study occurring November 2019 to March 2020 involving 504 assay plates detecting four Plasmodium antigens: pan-Plasmodium aldolase and lactate dehydrogenase (LDH), histidine-rich protein 2 (HRP2), P. vivax LDH (PvLDH). Controls on each plate included buffer blank, antigen negative blood, and 4-point positive dilution curve. The blank and negative blood provided consistently low signal for all targets except for pAldolase, which showed variability. Positive curve signals decreased throughout the 5-month study duration but retained a coefficient of variation (CV) of < 5%, with the exception of HRP2 in month 5 (CV of 11%). Regression fittings for inter-plate control signals provided mean and standard deviations (SDs), and of 504 assay plates, 6 (1.2%) violated the acceptable deviation limits and were repeated. For the 40,272 human blood samples assayed in this study, of 161,088 potential data points (each sample × 4 antigens), 160,641 (99.7%) successfully passed quality checks. The QA framework presented here can be utilized to ensure quality of laboratory antigen detection for large sample sets.


Subject(s)
Antigens, Protozoan/immunology , Malaria/immunology , Plasmodium/immunology , Adolescent , Antigens, Protozoan/blood , Child , Fructose-Bisphosphate Aldolase/immunology , Humans , L-Lactate Dehydrogenase/immunology , Nigeria , Protozoan Proteins/immunology , Quality Control , Serologic Tests/methods
6.
Mikrochim Acta ; 188(3): 88, 2021 02 16.
Article in English | MEDLINE | ID: mdl-33594523

ABSTRACT

A plasmon-enhanced fluorescence-based antibody-aptamer biosensor - consisting of gold nanoparticles randomly immobilized onto a glass substrate via electrostatic self-assembly - is described for specific detection of proteins in whole blood. Analyte recognition is realized through a sandwich scheme with a capture bioreceptor layer of antibodies - covalently immobilized onto the gold nanoparticle surface in upright orientation and close-packed configuration by photochemical immobilization technique (PIT) - and a top bioreceptor layer of fluorescently labelled aptamers. Such a sandwich configuration warrants not only extremely high specificity, but also an ideal fluorophore-nanostructure distance (approximately 10-15 nm) for achieving strong fluorescence amplification. For a specific application, we tested the biosensor performance in a case study for the detection of malaria-related marker Plasmodium falciparum lactate dehydrogenase (PfLDH). The proposed biosensor can specifically detect PfLDH in spiked whole blood down to 10 pM (0.3 ng/mL) without any sample pretreatment. The combination of simple and scalable fabrication, potentially high-throughput analysis, and excellent sensing performance provides a new approach to biosensing with significant advantages compared to conventional fluorescence immunoassays.


Subject(s)
Aptamers, Nucleotide/chemistry , Fluorescent Dyes/chemistry , L-Lactate Dehydrogenase/blood , Metal Nanoparticles/chemistry , Protozoan Proteins/blood , Antibodies, Immobilized/immunology , Biosensing Techniques/methods , Gold/chemistry , Humans , Immunoassay/methods , L-Lactate Dehydrogenase/immunology , Limit of Detection , Malaria/diagnostic imaging , Plasmodium falciparum/enzymology , Protozoan Proteins/immunology
7.
Signal Transduct Target Ther ; 5(1): 186, 2020 09 03.
Article in English | MEDLINE | ID: mdl-32883951

ABSTRACT

Sterol regulatory element binding protein-2 (SREBP-2) is activated by cytokines or pathogen, such as virus or bacteria, but its association with diminished cholesterol levels in COVID-19 patients is unknown. Here, we evaluated SREBP-2 activation in peripheral blood mononuclear cells of COVID-19 patients and verified the function of SREBP-2 in COVID-19. Intriguingly, we report the first observation of SREBP-2 C-terminal fragment in COVID-19 patients' blood and propose SREBP-2 C-terminal fragment as an indicator for determining severity. We confirmed that SREBP-2-induced cholesterol biosynthesis was suppressed by Sestrin-1 and PCSK9 expression, while the SREBP-2-induced inflammatory responses was upregulated in COVID-19 ICU patients. Using an infectious disease mouse model, inhibitors of SREBP-2 and NF-κB suppressed cytokine storms caused by viral infection and prevented pulmonary damages. These results collectively suggest that SREBP-2 can serve as an indicator for severity diagnosis and therapeutic target for preventing cytokine storm and lung damage in severe COVID-19 patients.


Subject(s)
Betacoronavirus/pathogenicity , Cholesterol/biosynthesis , Coronavirus Infections/genetics , Cytokine Release Syndrome/genetics , Host-Pathogen Interactions/genetics , Leukocytes, Mononuclear/immunology , Pneumonia, Viral/genetics , Sterol Regulatory Element Binding Protein 2/genetics , Betacoronavirus/immunology , COVID-19 , Case-Control Studies , Coronavirus Infections/immunology , Coronavirus Infections/mortality , Coronavirus Infections/virology , Cytokine Release Syndrome/immunology , Cytokine Release Syndrome/mortality , Cytokine Release Syndrome/virology , Gene Expression Regulation , Heat-Shock Proteins/genetics , Heat-Shock Proteins/immunology , Host-Pathogen Interactions/immunology , Humans , Intensive Care Units , Interleukin-1beta/genetics , Interleukin-1beta/immunology , L-Lactate Dehydrogenase/genetics , L-Lactate Dehydrogenase/immunology , Leukocytes, Mononuclear/metabolism , Leukocytes, Mononuclear/virology , Lung/immunology , Lung/metabolism , Lung/virology , NF-kappa B/genetics , NF-kappa B/immunology , Pandemics , Pneumonia, Viral/immunology , Pneumonia, Viral/mortality , Pneumonia, Viral/virology , Primary Cell Culture , Proprotein Convertase 9/genetics , Proprotein Convertase 9/immunology , SARS-CoV-2 , Signal Transduction , Sterol Regulatory Element Binding Protein 2/immunology , Survival Analysis , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/immunology
8.
Am J Trop Med Hyg ; 103(5): 1902-1909, 2020 11.
Article in English | MEDLINE | ID: mdl-32840197

ABSTRACT

In malaria-endemic countries, rapid diagnostic tests (RDTs) targeting Plasmodium falciparum histidine-rich protein 2 (PfHRP2) and lactate dehydrogenase (PfLDH) have been widely used. However, little is known regarding the diagnostic performances of these RDTs in the Assosa zone of northwest Ethiopia. The objective of this study was to determine the diagnostic performances of PfHRP2 and PfLDH RDTs using microscopy and quantitative PCR (qPCR) as a reference test. A health facility-based cross-sectional study design was conducted from malaria-suspected study participants at selected health centers from November to December 2018. Finger-prick blood samples were collected for microscopy, RDTs, and qPCR method. The prevalence of P. falciparum was 26.4%, 30.3%, and 24.1% as determined by microscopy, PfHRP2 RDT, and PfLDH RDT, respectively. Compared with microscopy, the sensitivity and specificity of the PfHRP2 RDT were 96% and 93%, respectively, and those of the PfLDH RDT were 89% and 99%, respectively. Compared with qPCR, the specificity of the PfHRP2 RDT (93%) and PfLDH RDT (98%) was high, but the sensitivity of the PfHRP2 RDT (77%) and PfLDH RDT (70%) was relatively low. These malaria RDTs and reference microscopy methods showed reasonable agreement with a kappa value above 0.85 and provided accurate diagnosis of P. falciparum malaria. Thus, the current malaria RDT in the Ministry of Health program can be used in the Assosa zone of Ethiopia. However, continuous monitoring of the performance of PfHRP2 RDT is important to support control and elimination of malaria in Ethiopia.


Subject(s)
Antigens, Protozoan/immunology , Diagnostic Tests, Routine/methods , L-Lactate Dehydrogenase/immunology , Malaria, Falciparum/diagnosis , Plasmodium falciparum/isolation & purification , Protozoan Proteins/immunology , Adolescent , Adult , Antigens, Protozoan/genetics , Child , Child, Preschool , Cross-Sectional Studies , Demography , Ethiopia , Female , Geography , Humans , L-Lactate Dehydrogenase/genetics , Malaria, Falciparum/parasitology , Male , Microscopy , Plasmodium falciparum/genetics , Plasmodium falciparum/immunology , Polymerase Chain Reaction , Protozoan Proteins/genetics , Sensitivity and Specificity , Young Adult
9.
Am J Trop Med Hyg ; 102(5): 1064-1067, 2020 05.
Article in English | MEDLINE | ID: mdl-32124720

ABSTRACT

Laboratory detection of malaria antigens has proved valuable for research and epidemiological purposes. We recently developed a bead-based multiplex antigen assay for pan-Plasmodium and Plasmodium falciparum targets. Here, we report integration of a Plasmodium vivax-specific target to this multiplex panel: P. vivax lactate dehydrogenase (PvLDH). Within the multiplex panel, assay signal for purified PvLDH antigen titrated into the single-digit picogram range. Against a panel of polymerase chain reaction (PCR)-confirmed samples from acute P. vivax infections (n = 36), sensitivity was 91.7% in using PvLDH detection for identifying the presence of parasites. Specificity against a panel of persons with no Plasmodium infection (n = 44) was 100%, and specificity against a panel of PCR-confirmed P. falciparum, Plasmodium malariae, or Plasmodium ovale infections (n = 164) was 90.2%. Addition of this PvLDH capture and detection system into the multiplex antigen panel will now allow for sensitive screening for species identification of both P. falciparum and P. vivax in the laboratory.


Subject(s)
Immunoassay/methods , L-Lactate Dehydrogenase/immunology , Plasmodium vivax/enzymology , Antigens, Protozoan/analysis , Antigens, Protozoan/immunology , L-Lactate Dehydrogenase/analysis , Plasmodium falciparum/enzymology , Plasmodium falciparum/immunology , Plasmodium vivax/immunology
10.
Sensors (Basel) ; 20(3)2020 Feb 01.
Article in English | MEDLINE | ID: mdl-32024098

ABSTRACT

The impact of malaria on global health has continually prompted the need to develop more effective diagnostic strategies that could overcome deficiencies in accurate and early detection. In this review, we examine the various biosensor-based methods for malaria diagnostic biomarkers, namely; Plasmodium falciparum histidine-rich protein 2 (PfHRP-2), parasite lactate dehydrogenase (pLDH), aldolase, glutamate dehydrogenase (GDH), and the biocrystal hemozoin. The models that demonstrate a potential for field application have been discussed, looking at the fabrication and analytical performance characteristics, including (but not exclusively limited to): response time, sensitivity, detection limit, linear range, and storage stability, which are first summarized in a tabular form and then described in detail. The conclusion summarizes the state-of-the-art technologies applied in the field, the current challenges and the emerging prospects for malaria biosensors.


Subject(s)
Biosensing Techniques , Diagnostic Tests, Routine/methods , Malaria, Falciparum/diagnosis , Plasmodium falciparum/immunology , Antigens, Protozoan/immunology , Antigens, Protozoan/isolation & purification , Fructose-Bisphosphate Aldolase/immunology , Fructose-Bisphosphate Aldolase/isolation & purification , Glutamate Dehydrogenase/immunology , Glutamate Dehydrogenase/isolation & purification , Hemeproteins/immunology , Hemeproteins/isolation & purification , Humans , L-Lactate Dehydrogenase/immunology , L-Lactate Dehydrogenase/isolation & purification , Malaria, Falciparum/genetics , Malaria, Falciparum/parasitology , Plasmodium falciparum/pathogenicity , Protozoan Proteins/immunology , Protozoan Proteins/isolation & purification
11.
IUBMB Life ; 72(5): 1065-1074, 2020 05.
Article in English | MEDLINE | ID: mdl-32083808

ABSTRACT

This study aimed to investigate the renal protective effect of atorvastatin (ATV) on the kidney inflammation induced by calcium oxalate (CaOx) crystals. A cell model of cell-crystal interactions and a rat model of CaOx kidney stone were established. The expressions of TLR4, NF-κB, NLRP3, and cleaved caspase-1 in cells and rat kidney tissues were detected using Western blot, immunohistochemical, and/or immunofluorescence. The concentrations of malondialdehyde (MDA), superoxide dismutase (SOD), reactive oxygen species (ROS) in cells, and lactic acid dehydrogenase (LDH) in the culture medium were measured. The secreted levels of interleukin (IL)-1ß, IL-18, IL-6, and tumor necrosis factor-α (TNF-α) were examined by ELISA. The serum levels of creatinine (CRE) and blood urea nitrogen (BUN) were measured. von Kossa staining was used for the evaluation of renal lens deposition. The CaOx model group showed significantly decreased SOD level; increased concentrations of MDA; ROS and LDH; elevated expressions of TLR4, NF-κB, NLRP3, and cleaved caspase-1; and the elevated release of IL-1ß, IL-18, IL-6, and TNF- α as compared to the control group. The treatment with ATV significantly inhibited the formation of CaOx kidney stone by increasing the level of SOD; downregulating MDA, ROS, and LDH; inhibiting the expressions of TLR4, NF-κB, NLRP3 and cleaved caspase-1; and blocking the secretion of inflammatory cytokines. In addition, the serum levels of CRE and BUN, and the intrarenal crystal deposition were also significantly decreased in ATV-treated rats. In summary, oxidative stress, TLR4/NF-κB, and NLRP3 inflammasome pathways are involved in renal inflammatory responses induced by CaOx crystals. ATV treatment significantly suppressed oxidative stress, inhibited the activation of TLR4/NF-κB and NLRP3 inflammasome pathways, and decreased the release of inflammatory mediators, thereby ameliorating CaOx crystal-induced damage and crystal deposition in HK-2 cells and rat kidney tissues.


Subject(s)
Antioxidants/pharmacology , Atorvastatin/pharmacology , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , NF-kappa B/genetics , NLR Family, Pyrin Domain-Containing 3 Protein/genetics , Nephrolithiasis/drug therapy , Toll-Like Receptor 4/genetics , Animals , Blood Urea Nitrogen , Caspase 1/genetics , Caspase 1/immunology , Creatinine/blood , Gene Expression Regulation , Inflammasomes/drug effects , Inflammasomes/immunology , Inflammasomes/metabolism , Interleukin-1beta/genetics , Interleukin-1beta/immunology , Interleukin-6/genetics , Interleukin-6/immunology , Kidney/drug effects , Kidney/metabolism , Kidney/pathology , L-Lactate Dehydrogenase/genetics , L-Lactate Dehydrogenase/immunology , Male , Malondialdehyde/immunology , Malondialdehyde/metabolism , NF-kappa B/immunology , NLR Family, Pyrin Domain-Containing 3 Protein/immunology , Nephrolithiasis/chemically induced , Nephrolithiasis/genetics , Nephrolithiasis/pathology , Oxidative Stress/drug effects , Rats , Rats, Sprague-Dawley , Reactive Oxygen Species/immunology , Reactive Oxygen Species/metabolism , Signal Transduction , Superoxide Dismutase/genetics , Superoxide Dismutase/immunology , Toll-Like Receptor 4/immunology
12.
Cancer Immunol Immunother ; 69(3): 449-463, 2020 Mar.
Article in English | MEDLINE | ID: mdl-31932876

ABSTRACT

Lactate dehydrogenase C (LDHC) is an archetypical cancer testis antigen with limited expression in adult tissues and re-expression in tumors. This restricted expression pattern together with the important role of LDHC in cancer metabolism renders LDHC a potential target for immunotherapy. This study is the first to investigate the immunogenicity of LDHC using T cells from healthy individuals. LDHC-specific T cell responses were induced by in vitro stimulation with synthetic peptides, or by priming with autologous peptide-pulsed dendritic cells. We evaluated T cell activation by IFN-γ ELISpot and determined cytolytic activity of HLA-A*0201-restricted T cells in breast cancer cell co-cultures. In vitro T cell stimulation induced IFN-γ secretion in response to numerous LDHC-derived peptides. Analysis of HLA-A*0201 responses revealed a significant T cell activation after stimulation with peptide pools 2 (PP2) and 8 (PP8). The PP2- and PP8-specific T cells displayed cytolytic activity against breast cancer cells with endogenous LDHC expression within a HLA-A*0201 context. We identified peptides LDHC41-55 and LDHC288-303 from PP2 and PP8 to elicit a functional cellular immune response. More specifically, we found an increase in IFN-γ secretion by CD8 + T cells and cancer-cell-killing of HLA-A*0201/LDHC positive breast cancer cells by LDHC41-55- and LDHC288-303-induced T cells, albeit with a possible antigen recognition threshold. The majority of induced T cells displayed an effector memory phenotype. To conclude, our findings support the rationale to assess LDHC as a targetable cancer testis antigen for immunotherapy, and in particular the HLA-A*0201 restricted LDHC41-55 and LDHC288-303 peptides within LDHC.


Subject(s)
Epitopes, T-Lymphocyte/immunology , HLA-A2 Antigen/immunology , Immunotherapy/methods , L-Lactate Dehydrogenase/immunology , Cell Line, Tumor , Female , Humans , Isoenzymes/immunology , Male
13.
J Immunol Res ; 2019: 4521231, 2019.
Article in English | MEDLINE | ID: mdl-31828172

ABSTRACT

High-altitude deacclimatization syndrome (HADAS) is involved in hypoxia-reoxygenation injury and inflammatory response, induced a series of symptoms, and has emerged as a severe public health issue. Here, we investigated the mechanism as well as potential means to prevent HADAS using Shenqi pollen capsules (SPCs) in subjects with HADAS in a multicenter, double-blinded, randomized, placebo-controlled study. All subjects were at the same high altitude (3650 m) for 4-8 months before returning to lower altitudes. Subjects (n = 288) in 20 clusters were diagnosed with mild or moderate HADAS on the third day of the study. We randomly allocated 20 clusters of subjects (1 : 1) to receive SPCs or a placebo for 7 weeks, and they were then followed up to the 14th week. The primary endpoints were subjects' HADAS scores recorded during the 14 weeks of follow-up. Compared with the placebo, SPC treatment significantly decreased the subjects' HADAS scores and reduced the incidence of symptom persistence. SPC therapy also reduced the serum levels of CK, CK-MB, LDH, IL-17A, TNF-α, and miR-155 and elevated IL-10 and miR-21 levels. We thus demonstrate that SPCs effectively ameliorated HADAS symptoms in these subjects via suppression of the hypoxia-reoxygenation injury and inflammatory response.


Subject(s)
Acclimatization/drug effects , Anti-Inflammatory Agents/therapeutic use , Drugs, Chinese Herbal/therapeutic use , Hypoxia/drug therapy , Oxygen/pharmacology , Adolescent , Adult , Altitude , Capsules , Casein Kinases/genetics , Casein Kinases/immunology , Double-Blind Method , Gene Expression/drug effects , Humans , Hypoxia/genetics , Hypoxia/immunology , Hypoxia/physiopathology , Inflammation , Interleukin-10/genetics , Interleukin-10/immunology , Interleukin-17/genetics , Interleukin-17/immunology , L-Lactate Dehydrogenase/genetics , L-Lactate Dehydrogenase/immunology , Male , MicroRNAs/genetics , MicroRNAs/immunology , Syndrome , Treatment Outcome , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/immunology
14.
Am J Trop Med Hyg ; 100(5): 1196-1201, 2019 05.
Article in English | MEDLINE | ID: mdl-30834883

ABSTRACT

Current malaria rapid diagnostic tests (RDTs) contain antibodies against Plasmodium falciparum-specific histidine-rich protein 2 (PfHRP2), Plasmodium lactate dehydrogenase (pLDH), and aldolase in various combinations. Low or high parasite densities/target antigen concentrations may influence the accuracy and sensitivity of PfHRP2-detecting RDTs. We analyzed the SD Bioline Malaria Ag P.f/Pan RDT performance in relation to P. falciparum parasitemia in Madagascar, where clinical Plasmodium vivax malaria exists alongside P. falciparum. Nine hundred sixty-three samples from patients seeking care for suspected malaria infection were analyzed by RDT, microscopy, and Plasmodium species-specific, ligase detection reaction-fluorescent microsphere assay (LDR-FMA). Plasmodium infection positivity by these diagnostics was 47.9%, 46.9%, and 58%, respectively. Plasmodium falciparum-only infections were predominant (microscopy, 45.7%; LDR-FMA, 52.3%). In all, 16.3% of P. falciparum, 70% of P. vivax, and all of Plasmodium malariae, Plasmodium ovale, and mixed-species infections were submicroscopic. In 423 P. falciparum mono-infections, confirmed by microscopy and LDR-FMA, the parasitemia in those who were positive for both the PfHRP2 and pan-pLDH test bands was significantly higher than that in those who were positive only for the PfHRP2 band (P < 0.0001). Plasmodium falciparum parasitemia in those that were detected as P. falciparum-only infections by microscopy but P. falciparum mixed infections by LDR-FMA also showed similar outcome by the RDT band positivity. In addition, we used varying parasitemia (3-0.0001%) of the laboratory-maintained 3D7 strain to validate this observation. A positive pLDH band in high P. falciparum-parasitemic individuals may complicate diagnosis and treatment, particularly when the microscopy is inconclusive for P. vivax, and the two infections require different treatments.


Subject(s)
Antigens, Protozoan/analysis , Diagnostic Tests, Routine/standards , L-Lactate Dehydrogenase/analysis , Malaria, Falciparum/diagnosis , Malaria, Vivax/diagnosis , Parasitemia/diagnosis , Protozoan Proteins/analysis , Antigens, Protozoan/immunology , Fructose-Bisphosphate Aldolase/analysis , Fructose-Bisphosphate Aldolase/immunology , Humans , L-Lactate Dehydrogenase/immunology , Madagascar , Microscopy , Plasmodium falciparum/enzymology , Plasmodium vivax , Protozoan Proteins/immunology , Sensitivity and Specificity
15.
J Infect Dis ; 219(3): 437-447, 2019 01 09.
Article in English | MEDLINE | ID: mdl-30202972

ABSTRACT

Background: Detection of Plasmodium antigens provides evidence of malaria infection status and is the basis for most malaria diagnosis. Methods: We developed a sensitive bead-based multiplex assay for laboratory use, which simultaneously detects pan-Plasmodium aldolase (pAldo), pan-Plasmodium lactate dehydrogenase (pLDH), and P. falciparum histidine-rich protein 2 (PfHRP2) antigens. The assay was validated against purified recombinant antigens, monospecies malaria infections, and noninfected blood samples. To test against samples collected in an endemic setting, Angolan outpatient samples (n = 1267) were assayed. Results: Of 466 Angolan samples positive for at least 1 antigen, the most common antigen profiles were PfHRP2+/pAldo+/pLDH+ (167, 36%), PfHRP2+/pAldo-/pLDH- (163, 35%), and PfHRP2+/pAldo+/pLDH- (129, 28%). Antigen profile was predictive of polymerase chain reaction (PCR) positivity and parasite density. Eight Angolan samples (1.7%) had no or very low PfHRP2 but were positive for 1 or both of the other antigens. PCR analysis confirmed 3 (0.6%) were P. ovale infections and 2 (0.4%) represented P. falciparum parasites lacking Pfhrp2 and/or Pfhrp3. Conclusions: These are the first reports of Pfhrp2/3 deletion mutants in Angola. High-throughput multiplex antigen detection can inexpensively screen for low-density P. falciparum, non-falciparum, and Pfhrp2/3-deleted parasites to provide population-level antigen estimates and identify specimens requiring further molecular characterization.


Subject(s)
Antigens, Protozoan/genetics , Antigens, Protozoan/immunology , Immunologic Tests , Plasmodium falciparum/genetics , Plasmodium falciparum/immunology , Protozoan Proteins/genetics , Protozoan Proteins/immunology , Adolescent , Adult , Angola , Antigens, Protozoan/blood , Child , Child, Preschool , Fructose-Bisphosphate Aldolase/immunology , Gene Deletion , Humans , Infant , L-Lactate Dehydrogenase/immunology , Malaria, Falciparum/diagnosis , Malaria, Falciparum/immunology , Malaria, Falciparum/parasitology , Middle Aged , Polymerase Chain Reaction , Protozoan Proteins/blood , Recombinant Proteins , Young Adult
16.
BMC Res Notes ; 11(1): 850, 2018 Dec 04.
Article in English | MEDLINE | ID: mdl-30509313

ABSTRACT

OBJECTIVE: Rapid diagnostic tests have been of tremendous help in malaria control in endemic areas, helping in diagnosis and treatment of malaria cases. It is heavily relied upon in many endemic areas where microscopy cannot be obtained. However, caution should be taken in the interpretation of its result in clinical setting due to its limitations and inherent weakness. This paper seeks to present the varying malaria RDT test results, the possible interpretations and explanation of these results common in endemic regions. Published works on malaria RDT studies were identified using the following search terms "malaria RDT in endemic areas", "Plasmodium falciparum and bacterial coinfection" "Plasmodium falciparum RDT test results in children in endemic areas" in Google Scholar and PubMed. RESULTS: The review results show that RDT positive results in febrile patients can either be true or false positive. True positive, representing either a possible single infection of Plasmodium or a co-infection of bacteria and P. falciparum. False RDT negative results can be seen in febrile patient with P. falciparum infection in prozone effect, Histidine rich protein 2 (HRP2) gene deletion and faulty RDT kits. Hence, a scale up of laboratory facilities especially expert microscopy and other diagnostic tools is imperative.


Subject(s)
Diagnostic Tests, Routine/statistics & numerical data , Fever/diagnosis , Malaria, Falciparum/diagnosis , Plasmodium falciparum/isolation & purification , Adult , Antigens, Protozoan/genetics , Antigens, Protozoan/immunology , Child , Diagnosis, Differential , False Negative Reactions , False Positive Reactions , Fever/physiopathology , Humans , L-Lactate Dehydrogenase/genetics , L-Lactate Dehydrogenase/immunology , Malaria, Falciparum/parasitology , Plasmodium falciparum/genetics , Plasmodium falciparum/immunology , Protozoan Proteins/genetics , Protozoan Proteins/immunology , Sensitivity and Specificity
18.
Fish Shellfish Immunol ; 74: 401-409, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29337249

ABSTRACT

Lactate dehydrogenase (LDH) is key for anaerobic glycolysis. LDH is induced by the hypoxia inducible factor -1 (HIF-1). HIF-1 induces genes involved in glucose metabolism and regulates cellular oxygen homeostasis. HIF-1 is formed by a regulatory α-subunit (HIF-1α) and a constitutive ß-subunit (HIF-1ß). The white spot syndrome virus (WSSV) induces anaerobic glycolysis in shrimp hemocytes, associated with lactate accumulation. Although infection and lactate production are associated, the LDH role in WSSV-infected shrimp has not been examined. In this work, the effects of HIF-1 silencing on the expression of two LDH subunits (LDHvan-1 and LDHvan-2) in shrimp infected with the WSSV were studied. HIF-1α transcripts increased in gills, hepatopancreas, and muscle after WSSV infection, while HIF-1ß remained constitutively expressed. The expression for both LDH subunits increased in each tissue evaluated during the WSSV infection, translating into increased enzyme activity. Glucose concentration increased in each tissue evaluated, while lactate increased in gills and hepatopancreas, but not in muscle. Silencing of HIF-1α blocked the increase of LDH expression and enzyme activity, along with glucose (all tissues) and lactate (gills and hepatopancreas) concentrations produced by WSSV infection. These results demonstrate that HIF-1 up regulates the expression of LDH subunits during WSSV infection, and that this induction contributes to substrate metabolism in energetically active tissues of infected shrimp.


Subject(s)
Gene Expression Regulation/immunology , Hypoxia-Inducible Factor 1/genetics , Immunity, Innate/genetics , L-Lactate Dehydrogenase/genetics , L-Lactate Dehydrogenase/immunology , Penaeidae/genetics , Penaeidae/immunology , Amino Acid Sequence , Animals , Arthropod Proteins/chemistry , Arthropod Proteins/genetics , Arthropod Proteins/immunology , Base Sequence , Gene Expression Profiling , Hypoxia-Inducible Factor 1/metabolism , L-Lactate Dehydrogenase/chemistry , Phylogeny , Sequence Alignment , White spot syndrome virus 1/physiology
19.
Malar J ; 17(1): 10, 2018 01 08.
Article in English | MEDLINE | ID: mdl-29310651

ABSTRACT

BACKGROUND: Malaria rapid diagnostic tests (RDTs) are a great achievement in implementation of parasite based diagnosis as recommended by World Health Organization. A major drawback of RDTs is lack of positive controls to validate different batches/lots at the point of care. Dried Plasmodium falciparum-infected samples with the RDT target antigens have been suggested as possible positive control but their utility in resource limited settings is hampered by rapid loss of activity over time. METHODS: This study evaluated the effectiveness of chemical additives to improve long term storage stability of RDT target antigens (HRP2, pLDH and aldolase) in dried P. falciparum-infected samples using parasitized whole blood and culture samples. Samples were treated with ten selected chemical additives mainly sucrose, trehalose, LDH stabilizer and their combinations. After baseline activity was established, the samples were air dried in bio-safety cabinet and stored at room temperatures (~ 25 °C). Testing of the stabilized samples using SD Bioline, BinaxNOW, CareStart, and First Response was done at intervals for 53 weeks. RESULTS: Stability of HRP2 at ambient temperature was reported at 21-24 weeks while that of PAN antigens (pLDH and aldolase) was 2-18 weeks of storage at all parasite densities. The ten chemical additives increased the percentage stability of HRP2 and PAN antigens. Sucrose alone and its combinations with Alsever's solution or biostab significantly increased stability of HRP2 by 56% at 2000 p/µL (p < 0.001). Trehalose and its combinations with biostab, sucrose or glycerol significantly increased stability of HRP2 by 57% (p < 0.001). Unlike sucrose, the stability of the HRP2 was significantly retained by trehalose at lower concentrations (500, and 200 p/µL). Trehalose in combination biostab stabilizer increased the percentage stability of PAN antigens by 42, and 32% at 2000 and 500 p/µL respectively (p < 0.01). This was also the chemical combination with the shortest reconstitution time (~ < 20 min). CONCLUSIONS: These findings confirm that stabilizing RDT target antigens in dried P. falciparum-infected samples using chemical additives provides field-stable positive controls for malaria RDTs.


Subject(s)
Chromatography, Affinity/methods , Chromatography, Affinity/standards , Diagnostic Tests, Routine/methods , Diagnostic Tests, Routine/standards , Malaria, Falciparum/diagnosis , Point-of-Care Systems , Reference Standards , Antigens, Protozoan/immunology , Humans , L-Lactate Dehydrogenase/immunology , Plasmodium falciparum/immunology , Protozoan Proteins/immunology , Temperature , Time Factors
20.
Mol Med Rep ; 17(3): 4011-4018, 2018 03.
Article in English | MEDLINE | ID: mdl-29257345

ABSTRACT

The role of resveratrol (trans-3,5,4'-trihydroxystilbene; RES) in lysophosphatidylcholine (LPC)­induced injury and inflammation in endothelial cells (regarded as an early event in arteriosclerosis) is unclear. The present study investigated whether RES reduces lactate dehydrogenase (LDH) activity and secretion of inflammatory cytokines such asinterleukin­6 and tumor necrosis factor­α, via the Toll­like receptor (TLR)­4/myeloid differentiation primary response gene 88 (MyD88)/nuclear factor (NF)­κB signal transduction pathway in LPC­induced damage and inflammation in human umbilical vein endothelial­12 (HUVE­12) cells. Using an ELISA and western blotting, the present study investigated the effects of RES on LDH activity and cytokine secretion. The effects of TLR­4 short hairpin (sh)RNA and TLR­4 cDNA transfection on NF­κB activation during LPC­induced damage and inflammation was also investigated in HUVE­12 cells. The results demonstrated that RES significantly inhibited the effect of LPC on enzyme activity, pro­inflammatory cytokine secretion, and expression of TLR­4, MyD88 and NF­κBp65 expression. In addition, RES and TLR­4 shRNA transfection suppressed LPC­induced injury and inflammation by blocking the TLR­4/MyD88/NF­κB signaling pathway Conversely, transfection with TLR­4 cDNA enhanced LPC­induced injury and inflammation, which abrogated the protective effects of RES. These data suggested that RES significantly suppressed LPC­induced damage and inflammation, via suppression of the TLR­4/MyD88/NF­κB signaling pathway, which may provide a new mechanistic evidence for the treatment of arteriosclerosis by RES.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Human Umbilical Vein Endothelial Cells/drug effects , Lysophosphatidylcholines/antagonists & inhibitors , Stilbenes/pharmacology , Toll-Like Receptor 4/genetics , Arteriosclerosis/genetics , Arteriosclerosis/immunology , Arteriosclerosis/pathology , Cell Line , DNA, Complementary/genetics , DNA, Complementary/metabolism , Gene Expression Regulation , Human Umbilical Vein Endothelial Cells/immunology , Human Umbilical Vein Endothelial Cells/pathology , Humans , Interleukin-6/antagonists & inhibitors , Interleukin-6/genetics , Interleukin-6/immunology , L-Lactate Dehydrogenase/genetics , L-Lactate Dehydrogenase/immunology , Lysophosphatidylcholines/pharmacology , Models, Cardiovascular , Myeloid Differentiation Factor 88/genetics , Myeloid Differentiation Factor 88/immunology , NF-kappa B/genetics , NF-kappa B/immunology , RNA, Small Interfering/genetics , RNA, Small Interfering/metabolism , Resveratrol , Signal Transduction , Toll-Like Receptor 4/antagonists & inhibitors , Toll-Like Receptor 4/immunology , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/immunology
SELECTION OF CITATIONS
SEARCH DETAIL